Its flagship project was intepirdine, an experimental 5-HT6 receptor antagonist it acquired ... deals involving a pair of gene therapies for GM1 and GM2 gangliosidosis – AXO-AAV-GM1 and AXO ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback